| Symbol | OXBOF |
|---|---|
| Name | OXFORD BIODYNAMICS PLC |
| Sector | UNDEFINED |
| Region | Europe |
| Industry | - |
| Address | |
| Telephone | — |
| Fax | — |
| — | |
| Website | https://www.oxfordbiodynamics.com/?doing_wp_cron=1 |
| Incorporation | GB |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | 9/30 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | — |
| Audit Status | AUDITED |
| Reporting Status | International Reporting: LSE - London Stock Exchange |
| CIK | — |
| Description | We are a biotechnology company with a proprietary epigenetic biomarker discovery platform, EpiSwitch, based on the latest advances in regulatory genome architecture and its link to clinical outcomes and patient stratification. Additional info from OTC: |
No news found.